Evaluates optimal delivery methods for three glycol vapors (propylene glycol, dipropylene glycol, and triethylene glycol) using commercially available, cost-effective emergency deployment technologies. The project investigates the potential of glycol vapors to facilitate the formation of unwanted secondary products or particulate matter that degrade air quality within a test office environment and assesses inactivation efficacy against three bacterial and viral cultures (Mycobacterium parafortuitum, Bordetella pertussis, and a vaccine strain of influenza) aerosolized in artificial saliva under controlled laboratory conditions.